University Of Texas Health is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Location: Houston, Texas, USA
Type: Academic Health Science Center
Founded: 1969
Affiliation: University of Texas System
Website: [https://www.uth.edu uth.edu]
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic health science center dedicated to advancing health care through excellence in education, research, and patient care. As part of the University of Texas System, UTHealth combines the resources of six schools, numerous research centers, and clinical practices to create a powerhouse for biomedical innovation in Texas.
The institution is a major hub for neurodegenerative disease research, particularly in Alzheimer's disease, Parkinson's disease, and stroke-related cognitive impairment.
¶ Schools and Components
The largest medical school in Texas, with over 1,000 students and extensive research programs in neuroscience and neurology.
Pioneering research in health informatics, AI for medical imaging, and computational neuroscience.
Population health research including epidemiology of neurodegenerative diseases.
Research on caregiving for patients with dementia and neurodegenerative conditions.
Research on oral-systemic health connections relevant to neurodegeneration.
The flagship center for neurodegenerative disease research at UTHealth:
- Alzheimer's Disease Research: Comprehensive program including clinical trials, biomarker development, and basic science
- Parkinson's Disease Program: Movement disorder research, deep brain stimulation, and non-motor symptom studies
- Stroke and Vascular Cognitive Impairment: Understanding vascular contributions to dementia
- ALS Research: Clinical trials and biomarker studies
¶ Center for Alzheimer's Care, Prevention, and Treatment
This center focuses on:
- Early detection and prevention strategies
- Lifestyle modification interventions
- Caregiver support programs
- Health disparities in Alzheimer's disease
Comprehensive program including:
- Motor and non-motor symptom management
- Deep brain stimulation programming
- Physical therapy and rehabilitation
- Genetic counseling
- Dean of the Graduate School of Biomedical Sciences (former)
- Distinguished neuroscientist specializing in Alzheimer's disease
- Key research: Synaptic changes in aging and Alzheimer's, estrogen effects on the brain
- Notable Publications:
- "Synaptic remodeling in the prefrontal cortex and hippocampus during aging" (Journal of Comparative Neurology)
- Multiple studies on estrogen and neuroprotection
- Sudha Seshadri, MD: Director of the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases
- Claudia Perez-Tobin, MD: Movement disorders specialist
- Michele Y. Johnson, MD: Cognitive neurologist
Named after a San Antonio businessman and community leader, this institute is UTHealth's flagship program for Alzheimer's disease and related disorders:
- Comprehensive memory assessment clinics
- State-of-the-art neuroimaging
- Clinical trials for new therapeutics
- Caregiver support and education programs
- Research on health disparities in Alzheimer's disease
- 3T and 7T MRI scanners
- PET imaging for amyloid and tau
- Advanced image analysis pipelines
- DNA banking and genetic counseling
- GWAS and sequencing studies
- Precision medicine approaches
- Inpatient and outpatient research facilities
- Clinical trials infrastructure
| Disease |
Research Focus |
| Alzheimer's Disease |
Biomarkers, clinical trials, synaptic mechanisms |
| Parkinson's Disease |
Movement disorders, DBS, non-motor symptoms |
| Vascular Cognitive Impairment |
Stroke, vascular dementia |
| ALS |
Clinical trials, biomarkers |
| Frontotemporal Dementia |
Language variants, behavior variants |
Comprehensive diagnostic and treatment services for:
- Alzheimer's disease
- Mild cognitive impairment
- Vascular dementia
- Lewy body dementia
- Frontotemporal dementia
Expert care for:
- Parkinson's disease
- Essential tremor
- Dystonia
- Huntington's disease
Multidisciplinary care including:
- Neurology
- Pulmonology
- Nutrition
- Physical therapy
- Social work
UTHealth collaborates extensively with:
- Texas Medical Center (world's largest medical complex)
- Baylor College of Medicine
- MD Anderson Cancer Center
- Michael J. Fox Foundation
- National Institute on Aging
- Alzheimer's Association
UTHealth offers comprehensive training in neurodegenerative diseases:
- Neurology residency
- Movement disorders fellowship
- Cognitive neurology fellowship
- Postdoctoral research training
- Graduate programs in neuroscience
- BIGFAST Trial: Investigating aggressive blood pressure control to prevent vascular cognitive impairment
- ALIZE Study: Novel imaging biomarker for early Alzheimer's detection
- Parkinson's Progression Markers Initiative (PPMI): Participation in this landmark PD study
- Texas Alzheimer's Research and Care Consortium: Statewide collaboration for Alzheimer's research
The study of University Of Texas Health has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Morrison JH, et al. "Neurobiological consequences of estrogen signaling in the aging female primate brain." Proceedings of the National Academy of Sciences. 2008.
- Selkoe DJ. "Resolving the debate on the role of soluble Aβ oligomers in Alzheimer's disease." Neuron. 2012.
- Jack CR Jr, et al. "NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease." Alzheimer's & Dementia. 2018.
- Poewe W, et al. "Parkinson disease." Nature Reviews Disease Primers. 2017.
- Corriveau RA, et al. "The Science of Alzheimer's Disease." Alzheimer's & Dementia. 2016.
- van der Flier WM, Scheltens P. "Alzheimer's disease." Lancet Neurology. 2020.
- Irwin DJ, et al. "Evaluation of potential prodromal Alzheimer's disease in a cohort of Parkinson's disease." JAMA Neurology. 2019.
- Sims JR, et al. "Donanemab in Early Symptomatic Alzheimer Disease." JAMA. 2023.